Teoman Şakalar

机构：Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi, Kahramanmaraş Sütçü İmam University, Marmara University · ORCID：0000-0003-2749-9414

发表论文 136 篇 · 总被引 354 次 · h-index 10

代表论文

Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer (2026 · Expert Review of Anticancer Therapy · 被引 2)
Glutamate dehydrogenase activity and non-ınvasive fibrosis ındices (APRI, AAR, FIB-4) compared to FibroScan in chronic hepatitis B and hepatocellular carcinoma (2026 · Irish Journal of Medical Science (1971 -) · 被引 1)
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study (2026 · Frontiers in Immunology · 被引 1)
Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study (2026 · International Journal of Cancer)
First-Line Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data from Turkey (2026 · Journal of Clinical Medicine)
Table 1_Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.docx (2026 · Figshare)